BioRestorative Therapies, Inc. (BRTX)

NASDAQ: BRTX · Real-Time Price · USD

0.3544

-0.0520 (-12.80%)

At close: Jun 2, 2026, 4:00 PM EDT

0.3577

+0.0033 (0.93%)

Pre-market: Jun 3, 2026, 8:40 AM EDT

BioRestorative Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.11	1.51	0.55	0.88	1.71	21.03
Short-Term Investments	0.48	1.44	10.18	10.18	13.04	-
Cash & Short-Term Investments	3.59	2.95	10.73	11.07	14.75	21.03
Cash Growth	-60.58%	-72.49%	-3.01%	-24.97%	-29.85%	586.11%
Accounts Receivable	0.01	0.02	0.19	0.02	0.02	0.01
Other Current Assets	0.19	0.17	0.22	0.31	0.36	0.44
Total Current Assets	3.8	3.14	11.14	11.39	15.13	21.47
Net Property, Plant & Equipment	0.33	0.36	0.36	0.51	0.5	0.4
Other Intangible Assets	0.51	0.53	0.62	0.71	0.8	0.59
Other Long-Term Assets	-	0.05	0.15	-	-	-
Total Assets	4.64	4.08	12.28	12.61	16.43	22.45
Accounts Payable	0.67	1.34	0.48	0.19	0.17	0.05
Accrued Expenses	0.95	0.98	0.74	0.71	0.13	0.13
Current Portion of Long-Term Debt	-	-	-	-	-	0.06
Current Portion of Leases	-	-	-	0.16	0.14	0.12
Other Current Liabilities	-	1.4	2.52	1.54	5.54	-
Total Current Liabilities	1.61	3.72	3.75	2.61	5.98	0.36
Long-Term Debt	-	-	-	-	-	0.19
Long-Term Leases	-	-	-	-	0.16	0.3
Total Long-Term Liabilities	-	-	-	-	0.16	0.49
Total Liabilities	1.61	3.72	3.75	2.61	6.14	0.86
Preferred Stock	-	0.01	0.01	0.01	0.02	0.02
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	175.1	170.26	164.2	156.69	146.56	155.73
Retained Earnings	-	-	-	-146.7	-136.28	-134.15
Shareholders' Equity	175.1	170.28	164.21	10	10.29	21.6
Total Liabilities & Equity	4.64	4.08	12.28	12.61	16.43	22.45
Total Debt	-	0	0	0.16	0.3	0.67
Net Cash (Debt)	3.59	2.95	10.73	10.9	14.45	20.36
Net Cash Growth	21.64%	-72.49%	-1.57%	-24.53%	-29.02%	-
Net Cash Per Share	0.32	0.33	1.38	2.58	3.99	17.14
Book Value	175.1	170.28	164.21	10	10.29	21.6
Book Value Per Share	15.45	18.93	21.15	2.37	2.84	18.18
Tangible Book Value	174.59	169.74	163.59	9.29	9.49	21.01
Tangible Book Value Per Share	15.41	18.87	21.07	2.20	2.62	17.69

SEC Filings: 10-K · 10-Q